Wockhardt Board of Directors

Get the latest insights into the leadership at Wockhardt. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Habil Khorakiwala Founder Chairman
Dr. Murtaza Khorakiwala Managing Director
Dr. Huzaifa Khorakiwala Executive Director
Ms. Zahabiya Khorakiwala Non Executive Director
Mrs. Tasneem Mehta Independent Director
Mr. Vinesh Kumar Jairath Independent Director
Mr. Akhilesh Gupta Independent Director
Ms. Amelia Fernandes Independent Director
Mr. Ahmad Javed Independent Director

Wockhardt Share price

WOCKPHARMA

1475.9

12.10 (-0.81%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:51 IST
BUYSELL
Today's High

1514.00

Today's Low

1471.80

52 Week Low

915.00

52 Week High

1868.80

The current prices are delayed, login to your account for live prices

Wockhardt FAQs

The board at Wockhardt consists of experienced professionals, including Dr. Habil Khorakiwala , Dr. Murtaza Khorakiwala , and others, overseeing the company’s strategic and corporate governance.

Directors at Wockhardt are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Habil Khorakiwala is the current chairman at Wockhardt.

Executive directors at Wockhardt are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Wockhardt adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Wockhardt, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.